Advancing Liver Care Through Innovative Associate & APP-Led Strategies
Nov
09
2025
Convention Center: Room 146C, Level 1
3:45 PM
- 4:45 PM
Description
This session highlights the vital contributions of associates and advanced practice providers (APPs) in advancing hepatology care through real-world insights, innovative treatment strategies, and impactful quality improvement initiatives. Through data-driven research and patient-centered approaches, these presenters demonstrate the power of associate- and APP-led initiatives to improve outcomes and expand access in diverse clinical settings.Journey Maps
Presentations
3:45 PM
- 4:00 PM
May
19
2026
Washington, D.C.
Real-world insights into Progressive Familial Intrahepatic Cholestasis: Initial Data from the TreatFIC Registry
Robin Soto, MSN, FNP-BC
, Abstract Presenter
ALD
Cholestatic and Autoimmune
Hepatology Associates
4:00 PM
- 4:15 PM
May
19
2026
Washington, D.C.
Improving Access to Alcohol Use Disorder Pharmacotherapy in Hepatology: A Quality Improvement Initiative
Kristine Drozd, MSN, NP-C
, Abstract Presenter
ALD
Cholestatic and Autoimmune
Hepatology Associates
Objectives
- Describe the clinical significance and evolving management strategies for patients with rare cholestatic liver diseases, including insights from prospective registries.
- Evaluate strategies to optimize transplant outcomes through better risk stratification and post-transplant behavioral support.
- Apply real-world, APP-led interventions to enhance symptom control, improve access to care, and support high-risk populations across hepatology care settings.